arrow
K

Koen Norga

harvard university medical affiliates
H指数:31
被引数:9,478

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
2023-09-016
OAAI
Paediatric Strategy Forum for medicinal product development in mitogen-activated protein kinase pathway inhibitors ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
2022-12-019
OAAI
Paediatric Inflammatory Bowel Disease: A Multi-Stakeholder Perspective to Improve Development of Drugs for Children and Adolescents
2022-09-2114
OAAI
Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
2022-09-0112
OA
ACCELERATE-Five years accelerating cancer drug development for children and adolescents
2022-05-0130
OA
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

儿童和青少年癌症患者嵌合抗原受体T细胞药物产品开发儿科战略论坛与欧洲药品管理局合作,食品和药物管理局参与加速

2022-01-0127
OA
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration
2021-11-0136
OA
Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
2020-11-0118
OAAI
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

儿童和青少年急性髓性白血病药物产品开发儿科战略论坛与欧洲药品管理局合作加速,食品和药物管理局参与

2020-09-0131
OAAI
Joint adolescent-adult early phase clinical trials to improve access to new drugs for adolescents with cancer: proposals from the multi-stakeholder platform-ACCELERATE
2018-03-0156
OAAI
Differential impact of drugs on the outcome of ETV6-RUNX1 positive childhood B-cell precursor acute lymphoblastic leukaemia: results of the EORTC CLG 58881 and 58951 trials
LEUKEMIA
IF13.4
2017-09-199
OAAI
Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

加速神经母细胞瘤的药物开发-新药开发战略: 儿童癌症的创新疗法,欧洲儿童和青少年癌症研究网络和国际儿科肿瘤学会欧洲神经母细胞瘤项目

2017-06-2640
OAAI
Implementation of mechanism of action biology-driven early drug development for children with cancer
2016-07-0155
PREAI